086040 — Biotoxtech Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapSucker Stock

Annual cashflow statement for Biotoxtech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	2,367	6,980	1,512	-8,950	-12,657
Depreciation
Amortisation
Non-Cash Items	-840	-1,227	3,467	2,212	8,515
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	1,406	-3,078	-8,232	-13,179	-7,076
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	4,564	4,346	-1,309	-16,238	-7,120
Capital Expenditures	-2,540	-7,956	-30,785	-4,883	-2,381
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-4,465	199	4,387	2,904	-7,459
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-7,005	-7,757	-26,399	-1,978	-9,841
Financing Cash Flow Items	-11.4	-181	-5.43	216	-227
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-141	19,279	21,929	33,022	762
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-2,630	15,845	-5,892	14,779	-16,109